# A Study of Two Doses of MRC375 in Moderate to Severe Rheumatoid Arthritis Patients

> **NCT01408602** · PHASE2 · UNKNOWN · sponsor: **Molecular Research Center, Inc.** · enrollment: 300 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** MRC375
- **DRUG:** Matching Placebo
- **DRUG:** MRC375 150mg

## Key facts

- **NCT ID:** NCT01408602
- **Lead sponsor:** Molecular Research Center, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-11
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2014-05-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01408602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01408602, "A Study of Two Doses of MRC375 in Moderate to Severe Rheumatoid Arthritis Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01408602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*